The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Functional improvement of dystrophic muscle by myostatin blockade
Abstract
Mice and cattle with mutations in the myostatin (GDF8) gene show a marked increase in body weight and muscle mass, indicating that this new member of the TGF-beta superfamily is a negative regulator of skeletal muscle growth. Inhibition of the myostatin gene product is predicted to increase muscle mass and improve the disease phenotype in a variety of primary and secondary myopathies. We tested the ability of inhibition of myostatin in vivo to ameliorate the dystrophic phenotype in the mdx mouse model of Duchenne muscular dystrophy (DMD). Blockade of endogenous myostatin by using intraperitoneal injections of blocking antibodies for three months resulted in an increase in body weight, muscle mass, muscle size and absolute muscle strength in mdx mouse muscle along with a significant decrease in muscle degeneration and concentrations of serum creatine kinase. The functional improvement of dystrophic muscle by myostatin blockade provides a novel, pharmacological strategy for treatment of diseases associated with muscle wasting such as DMD, and circumvents the major problems associated with conventional gene therapy in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The interest in myostatin was generated by recent studies where antibodies for myostatin were created and administered to adult rodents, which resulted in an increase in body mass, muscle mass, muscle size, and strength [11,12].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [12]
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
TEXTBOOK OF MEDICAL PHYSIOLOGY
GUYTON, A. C. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196701000-00031 · Cited by 2,837
Dystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802 · cited 1×
“In comparison with conventional transgenic, cell and gene therapy approache”
BackgroundX chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616 · cited 1×
“Alterations in Smad 2 and 3 phosphorylation would be predicted to regulate the formation of Smad complexes, their nuclear translocation and transcriptional regulation of genes associated with commitment of muscle progenitor”
BackgroundA deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526 · cited 1×
“The regimen did not completely reverse dystrophic changes; physiological parameters evaluated by ex vivo tests, such as susceptibility to damage by lengthening contraction”
BackgroundAhima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Self-citationSmad regulation in TGF-β signal transduction
Moustakas, A., Souchelnytskyi, S., & Heldin, C.-H. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.24.4359 · Cited by 929
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., Narusawa, M., Leferovich, J. M., Sladky, J. T., & Kelly, A. M. (1991) · Nature · doi:10.1038/352536a0 · Cited by 926 · cited 1×
“To examine for histological evidence of improvement, we sectioned the diaphragm in addition to EDL, because the diaphragm rather than EDL shows degeneration and fibrosis by 16 week”
MethodTripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628 · cited 1×
“Furthermore, our approach should obviate the problems concerning toxicity or immune response against the vector, which has been of concern in recent therapeutic trials using conventional gene therap”
MethodAmelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., & Davies, K. E. (1996) · Nature · doi:10.1038/384349a0 · Cited by 490 · cited 1×
“In comparison with conventional transgenic, cell and gene therapy approache”
BackgroundMatsuda, R., Nishikawa, A., & Tanaka, H. (1995) · Journal of Biochemistry · doi:10.1093/jb/118.5.959 · Cited by 362
TORRES, L. F. B., & DUCHEN, L. W. (1987) · Brain · doi:10.1093/brain/110.2.269 · Cited by 352
COULTON, G. R., MORGAN, J. E., PARTRIDGE, T. A., & SLOPER, J. C. (1988) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1988.tb00866.x · Cited by 344
Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch
Moens, P., Baatsen, P. H. W. W., & Mar�chal, G. (1993) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf00121296 · Cited by 328 · cited 1×
“The regimen did not completely reverse dystrophic changes; physiological parameters evaluated by ex vivo tests, such as susceptibility to damage by lengthening contraction”
BackgroundTries, R. S., Chen, T., Da Vies, M. V., Tomkinson, K. N., Pearson, A. A., Shakey, Q. A., & Wolfman, N. M. (2001) · Growth Factors · doi:10.3109/08977190109029114 · Cited by 265 · cited 1×
“Cultured C 2 C 12 muscle cells were treated with blocking antibodies generated against myostati”
MethodImmunolocalization and developmental expression of dystrophin related protein in skeletal muscle
Khurana, T. S., Watkins, S. C., Chafey, P., Chelly, J., Tomé, F. M. S., Fardeau, M., Kaplan, J.-C., & Kunkel, L. M. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90023-l · Cited by 263 · cited 1×
“3c ) revealed normal concentrations of utrophin enrichment at the synaptic regions of the muscle, suggesting that myostatin blockade ameliorated the dystrophic phenotype via a utrophin-independent mechanis”
BackgroundSelf-citationConservation of the Duchenne Muscular Dystrophy Gene in Mice and Humans
Hoffman, E. P., Monaco, A. P., Feener, C. C., & Kunkel, L. M. (1987) · Science · doi:10.1126/science.3659917 · Cited by 258
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G., & McNally, E. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01570-2 · Cited by 227
Identification of a chromosome 6-encoded dystrophin-related protein.
Khurana, T. S., Hoffman, E. P., & Kunkel, L. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44816-2 · Cited by 206
Self-citationToxicity of a First-Generation Adenoviral Vector in Rhesus Macaques
Lozier, J. N., Csákó, G., Mondoro, T. H., Krizek, D. M., Metzger, M. E., Costello, R., Vostal, J. G., Rick, M. E., Donahue, R. E., & Morgan, R. A. (2002) · Human Gene Therapy · doi:10.1089/10430340152712665 · Cited by 128 · cited 1×
“Furthermore, our approach should obviate the problems concerning toxicity or immune response against the vector, which has been of concern in recent therapeutic trials using conventional gene therap”
MethodMuscular weakness in the mdx mouse
Muntoni, F., Mateddu, A., Marchei, F., Clerk, A., & Serra, G. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90027-v · Cited by 111 · cited 1×
“Mdx mice have previously been shown to have an impaired ability to maintain grip and suspend themselves against gravity on the Rota-ro”
BackgroundExpression profiling reveals metabolic and structural components of extraocular muscles
Fischer, M. D., Gorospe, J. R., Felder, E., Bogdanovich, S., Domellöf, F. P., Ahima, R. S., Rubinstein, N. A., Hoffman, E. P., & Khurana, T. S. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00115.2001 · Cited by 100
Self-citationExpression Profiling Reveals Metabolic and Structural Components of Extraocular Muscles
Fischer, �., Gorospe, J. R. M., Felder, E., Bogdanovich, S., Domellöf, F. P., Ahima, R., Rubinstein, N., Hoffman, E. P., & Khurana, T. (2002) · Investigative Ophthalmology & Visual Science · Cited by 88
Self-citationContinuous myonuclear addition to single extraocular myofibers in uninjured adult rabbits
McLoon, L. K., & Wirtschafter, J. D. (2002) · Muscle & Nerve · doi:10.1002/mus.10056 · Cited by 75 · cited 1×
“Interestingly, increased regeneration and/or myogenesis in extraocular muscles has recently been suggested as an important mechanism for the clinical and pathological sparing of this muscle group in DM”
BackgroundEbihara, S., Guibinga, G.-H., Gilbert, R., Nalbantoglu, J. N., Massie, B., Karpati, G., & Petrof, B. J. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.3.3.133 · Cited by 67
Dystrophin : gene, protein, and cell biology
Brown, S., & Lucy, J. A. (1997) · Cambridge University Press eBooks · Cited by 51
Dystrophin: Gene, protein and cell biology
Khurana, T. S. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)89825-8 · Cited by 8
Self-citation
Research works printed but not linked: 2
- Jalenak, M. et al. Transcriptional changes arising from in vivo inhibition of myostatin. J. Neurol. Sci. 199 (suppl)., S83 (2002)
- Engel, A. G. & Franzini-Armstrong, C. Myology (McGraw-Hill, New York, 1994)
Cited by
Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
“, 2002), and conversely, inhibition by various genetic means promotes a doubling in muscle mass and myofiber size (Bogdanovich et al., 2002; Whittemore et al., 2003; Lee et al., 2005; Welle et al., 2007).”
BackgroundMuscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
“It appears that mdx mice injected with myostatin antibodies for 3 mo showed an increase in muscle mass (11).”
BackgroundREGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Metadata
- Authors
- Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S.
- Affiliations
- University of Pennsylvania (US)
- Pfizer (United States) (US)
- Corresponding author
- Khurana, Tejvir S.
- Venue
- Nature
- Published
- 2002-11
- Volume
- 420
- Issue
- 6914
- Pages
- 418-421
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083700023
- Semantic Scholar
- 590fb54cd1f2d89d44f4e1ad999be802dc756277
- Cited by
- 831
- References
- 31
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 19 · 2023: 15 · 2022: 21 · 2021: 20 · 2020: 23 · 2019: 32 · 2018: 23 · 2017: 34 · 2016: 28 · 2015: 43 · 2014: 34 · 2013: 38 · 2012: 48
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- myostatin, Duchenne muscular dystrophy, mdx mice, muscle atrophy, blocking antibodies, muscle mass, muscle strength, muscle degeneration, creatine kinase, TGF-beta superfamily, skeletal muscle growth
- MeSH terms
- Animals, Antibodies, Body Weight, Creatine Kinase, Male, Muscular Dystrophy, Animal, Organ Size, Transforming Growth Factor beta, Mice, Inbred mdx, Muscle, Skeletal, Muscle Fibers, Skeletal, Muscular Dystrophy, Duchenne, Mice, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.